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Abstract
Background:  A considerable number of patients require opioids during recovery after
laparoscopic sterilization. This implies nausea, dizziness and sedation and increases the number of
unplanned admissions. Gabapentin has shown excellent postoperative analgesic effect in a number
of recent studies with few side effects. This study was designed to test whether gabapentin given
preoperatively can reduce the number of patients needing morphine in the recovery period.
Methods: 80 females scheduled for laparoscopic sterilization using Filshie clips were randomized
to two treatment groups (Gaba group and control group).
All patients received lornoxicam 8 mg p.o. 30 min. before the procedure. Patients in the Gaba
group received gabapentin 1200 mg p.o. and patients in the control group received placebo
capsules prior to the procedure. All patients were anesthetized according to a protocol, using
remifentanil and propofol.
Postoperative analgesia was obtained with patient controlled infusion of morphine. Pain, nausea,
dizziness and sedation were scored at 2 and 4 hours after end of anesthesia. The expenditure of
morphine was the primary measure for the effect of analgesia and the number of patients
demanding morphine was the primary endpoint.
Results:  Three patients were excluded because of procedural errors and one because of
conversion to open surgery. 38 patients completed the study in each group.
32 (84%) patients in the gabapentin group and 37 (97%) patients in the control group did require
morphine in the recovery period. (p = 0,049).
There was no significant difference between mean morphine consumption, pain scores and
frequency of adverse effects (nausea, dizziness, sedation and vomiting)
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Conclusion : The postoperative analgesic effect of gabapentin given preoperatively was confirmed
in this study. For this procedure, with pain predominantly in the immediate recovery period, and
of less intensity than after major surgical procedures, the effect demonstrated is much less
pronounced than in similar studies of major surgery. General use of gabapentin as analgesic for
laparoscopic sterilization is not supported by this study.
Trial Registration: Current Controlled Trials ISCRTN39209275
Background
Laparoscopic sterilization of females is a procedure well
suited for day surgery. A considerable number of patients
however, require opioids in the recovery period [1], delay-
ing the time for street fitness and implying a number of
unplanned admissions due to nausea, dizziness and seda-
tion.
An analgesic regimen with less adverse effects is thus desir-
able.
Recently, gabapentin has been introduced as an adjunc-
tive analgesic drug in the perioperative setting, and results
so far are promising [2-8]. A number of meta-analyses
have been conducted showing reduced pain and opioid
requirements when gabapentin was administered preop-
eratively [9-12]. Although data so far are insufficient for
firm conclusions, the most recent meta-analysis demon-
strated both reduced pain and opioid requirements as
well as less opioid-related side effects such as vomiting
and pruritus [12].
This study was designed to test whether gabapentin com-
bined with the NSAID lornoxicam given preoperatively
can reduce the need for postoperative morphine com-
pared with preoperative lornoxicam alone in patients
scheduled for laparoscopic sterilization.
Methods
Women aged 26–45 yr scheduled for laparoscopic sterili-
zation using Filshie clips were eligible for the study.
Patients were not included if they were unable to cooper-
ate, were breast feeding, had known allergy to gabapentin
or morphine, a history of drug or alcohol abuse, chronic
pain or daily intake of analgesics or corticosteroids, diabe-
tes, or impaired kidney function. Patients with an intake
of NSAIDs or paracetamol 24 h prior to operation or an
intake of antacids 48 h prior to operation were also
excluded from the study. Patients were recruited from the
Day Surgical Departments of Copenhagen University
Hospital, Herlev (Herlev, Denmark) and Copenhagen
University Hospital, Glostrup (Glostrup, Denmark) dur-
ing the period September 2002 to November 2004. Writ-
ten informed consent was obtained from all patients, and
the study was approved by the Regional Ethics Committee
(Herlev, Denmark) and The Danish Medicine Agency
(Copenhagen, Denmark).
Interventions
Patients received oral lornoxicam 8 mg, combined with
oral gabapentin 1.200 mg or placebo, 30 min before sur-
gery.
General anesthesia was induced with 1.5–2.5 mg/kg pro-
pofol, and infusion of 1 μg/kg remifentanil for 1 min.
A pro seal laryngeal mask (LMA-PS) was inserted. A
nasogastric tube was introduced through the LMA-PS to
drain the stomach of air. Liquid gastric content was
returned through the nasogastric tube. Anesthesia was
maintained with infusion of propofol at the discretion of
the anesthetist, and a fixed infusion of 0.4 μg·kg-1 min-1
remifentanil. Hypotension was treated with 5 mg ephe-
drine intravenously in incremental doses, in order to pre-
serve systolic blood pressure above 90 mmHg. The
infusions of propofol and remifentanil were terminated at
skin closure; 0.5 mg alfentanil was administered intrave-
nously to all patients, who were then transferred to the
postoperative care unit. Postoperative pain treatment con-
sisted of patient-controlled intravenous morphine
(Abbott Pain Management Provider; Abbott, Virum, Den-
mark). Initial bolus dose was 5 mg, supplemental bolus
doses were 2.5 mg. Lock-out time was 10 min. Additional
morphine, 2.5 mg intravenously, was administered by a
nurse observer, if requested by the patient, during the
lock-out period. Ondansetron, 4 mg intravenously, was
administered on patient request. No other medications
were administered during the 4-h observation period.
Outcomes and assessments
The primary outcome measure was number of patients
requesting morphine during the first 4 postoperative
hours.
Secondary outcome measures were: Total morphine con-
sumption from 0 to 4 h postoperatively; pain at rest and
during mobilization from the supine to the sitting posi-
tion, and side effects: nausea, sedation, dizziness, and
vomiting.BMC Anesthesiology 2006, 6:12 http://www.biomedcentral.com/1471-2253/6/12
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Before surgery, all patients were instructed in the use of
patient-controlled analgesia (PCA) and the visual ana-
logue score (VAS) (0 mm: no pain, 100 mm: worst pain
imaginable). Total morphine consumption was recorded
from 0 to 4 h postoperatively. Pain scores at rest and dur-
ing mobilization were assessed by the patients at 2 and 4
h after surgery.
Side effects were rated on a four-point verbal scale (none,
mild, moderate, severe) at 2 and 4 h after surgery.
The number of patients vomiting, as well as use of
antiemetics, was recorded.
Study population size
Based on registration of morphine administration for this
procedure during the year before the study 60 % of
patients had morphine in the postoperative period after
laparoscopic sterilization. We considered a 30 % reduc-
tion in this frequency to be clinically relevant. With a type
1 error of 5 % and a power of 90% 38 patients were
required in each study group.
Blinding
The study was randomized, double-blind, and placebo
controlled. Study medication was prepared by the hospi-
tal pharmacy into identical capsules containing either 300
mg gabapentin, or placebo. Study medication was marked
with the name of the project, the investigator's name, and
consecutive numbers according to a computer-generated
block randomization schedule prepared by the hospital
pharmacy. Patients were enrolled by the same investiga-
tors who also performed the assessments. Participants
were assigned consecutively to their group according to
their number. No person was aware of group assignment
until all patients had been included and assessments were
completed.
Statistical methods
The Kolmogorov-Smirnov one-sample test for normality
(K-S) was performed on the data sets to examine if t-test
was possible. The K-S test was significant for all data sets
except total morphine consumption. Consequently total
morphine consumption was compared using Students t-
test, and all other variables were compared using Mann-
Whitney rank sum test for unpaired data.
Bonferronis correction was used for multiple compari-
sons.
Data are presented as medians with lower and upper quar-
tiles. Calculations were performed using SPSS 13.0 for
Windows (SPPS, Chicago, IL). The statistical analysis was
performed by the investigators.
Results
181 consecutive patients who fulfilled the inclusion crite-
ria were considered for inclusion in the study (Fig. 1).
Eighty patients were included in the study; four of these
were subsequently excluded, two in the gabapentin and
two in the placebo group. Three patients were given doses
of lornoxicam preoperatively other than prescribed in the
study protocol, two in the placebo group and one in the
gabapentin group. One procedure in the gabapentin
group was conversed to open surgery during the opera-
tion.
Data from 76 patients, 38/40 in the gabapentin group and
38/40 in the placebo group, were analyzed.
Baseline demographic and clinical characteristics of each
group are shown in Table 1. No significant differences
were observed between groups.
Number of patients requesting morphine
Thirty-two of 38 patients in the gabapentin group and 37/
38 patients in the control group did require morphine in
the postoperative period. The difference is significant (p =
0.049)
Morphine consumption
No statistically significant difference in the median
amount of morphine required during the first 4 postoper-
ative hours was found (table 2).
Pain scores
No significant differences between pain scores at rest or
during mobilization were found at any assessment (Table
3).
Side-effects
The incidence of side-effects appears from Table 4. No sig-
nificant differences were observed in any outcome
between groups (P > 0.05 for all observations).
Discussion
This study did show a significant reduction in the number
of patients requiring morphine after laparoscopic sterili-
zation. (The primary outcome parameter). In contrast to
other studies, the reduction in mean amount of morphine
used was small and not statistically significant. The clini-
cal implication is that gabapentin is not likely to be of use
in this setting.
The only earlier study of the effect of gabapentin on post-
operative pain after a laparoscopic procedure did show a
marked effect of a small dose of gabapentin given preop-
eratively on pain and opioid consumption after laparo-
scopic cholecystectomy [13]. In this study no additional
analgesic was given beside the "rescue" drug (fentanyl).BMC Anesthesiology 2006, 6:12 http://www.biomedcentral.com/1471-2253/6/12
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The sensitivity of the current study was reduced by the
design, where both groups did receive NSAID (lornoxi-
cam). This study does actually compare the use of gabap-
entin versus placebo as an additive to NSAID for pain after
sterilization. This was done for ethical reasons, as preop-
erative NSAID is routinely used for this procedure in our
institutions. The efficacy of NSAID per se in postoperative
pain control after laparoscopic sterilization is difficult to
estimate based on the literature, as CRT's give result rang-
ing from non significant effect to elimination of the need
for morphine [1,14-19]. In our institutions data from the
local quality assurance database did show that 60% of the
patients did require postoperative opioid administration
despite routine preoperative administration of NSAID.
Another factor diminishing the sensitivity of this study to
demonstrate analgesic effect of gabapentin might be the
short interval between the administration of gabapentin
and the end of surgery. Gabapentin concentrations might
not have reached optimal levels in all cases in the imme-
diate recovery period. However: To be useful in day sur-
gery, a drug has to be active within an hour after
administration so the design reflects the clinical reality.
The technique of using the consumption of morphine
during PCA treatment of postoperative pain, as a measure
of the effect of the analgesic regime under study, has been
used in several other studies of this kind [5,6]. Due to the
delayed onset of the analgesic effect of morphine, titration
for optimal pain control might be rather difficult for the
patient in the immediate recovery period. This might be a
minor drawback, when a postoperative analgesic regimen
for major surgery is the object of study, but it diminishes
the sensitivity of the technique severely, when the period
of severe pain, is limited to few hours postoperatively. In
Table 1: Demographics
Gabapentin Control
Number of patients (n) 38 38
Age 37 (28–45) 38 (27–45)
Height (cm) 165 (151–184) 168 (154–179)
Weight (kg) 65 (47–110) 64 (49–110)
Duration of surgery (min) 34 (16–77) 29 (14–65)
Patient and perioperative data (median and range).
No significant differences between groups.
Flow diagram of patient distribution Figure 1
Flow diagram of patient distribution.
 
Assessed for eligibility 
(n= 181) 
Randomized (n=80) 
Excluded (n=111) 
(Did not accept participation = 57 Chronical pain 
=13; Breastfeeding=8; Psychiatric disease=7; 
Other surgical procedure. 5; Allergy=5; 
Diabetes=3; Interactions=4; Cancellations=6; 
History of drug addiction=3 
Allocated to gabapentin (N=40)  Allocated to placebo (N=40) 
Lost to follow-up (n= 2) 
(Error in preoperative lornoxicam dose=1; 
Conversion to open surgery =1) 
Lost to follow-up (n= 2) 
(Error in preoperative lornoxicam dose=2) 
Analyzed (n=38)  Analyzed (N=38) BMC Anesthesiology 2006, 6:12 http://www.biomedcentral.com/1471-2253/6/12
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future studies in the setting of day surgery, it might be
appropriate to use opioids with a shorter onset time and
time of action than morphine.
The frequency of side effects was not different between the
groups in this study. However the study was not dimen-
sioned to disclose such a difference, and a type 2 error in
these the results is quite likely. A non significant trend in
the results with a slightly higher frequency of dizziness in
the gabapentin group and a slightly higher frequency of
nausea in the control group is noted. This is in accordance
with earlier studies in the ambulatory surgical setting [3]
Conclusion
The postoperative analgesic effect of gabapentin given
preoperatively was confirmed in this study. For this proce-
dure, with pain predominantly in the immediate recovery
period, and of less intensity than after major surgical pro-
cedures, the effect demonstrated is much less pronounced
than in similar studies of major surgery. General use of
gabapentin as analgesic for laparoscopic sterilization is
not supported by this study.
Table 2: Morphine consumption:
Gabapentin (n = 38) Control (n = 38) P
Number of patients consuming morphine postoperatively 32 (84%) 37 (97%) 0.0491
Total consumption of morphine in mg
(mean ± st. dev)
10.5 ± 7,1 13.7 ± 7,4 0.0592
Frequency of demand for morphine (PCA) postoperatively and mean consumption of morphine (PCA) postoperatively.
(1: Mann-Witney; 2: Student t)
Table 3: Pain scores
Gabapentin (n = 38) Control (n = 38) P (Mann-witney)
VAS at rest 2 hours after operation 13 (7–28) 22.5 (11–35) 0.06
VAS at rest 4 hours after operation 4 (0–10) 6 (1–11) 0.22
VAS sitting up 2 hours after operation 8 (4.5–26) 20(6.5–29) 0.26
VAS sitting up 4 hours after operation 3 (0–10) 5 (1–14) 0.49
Pain scores (VAS median, lower and upper quartile) at rest and when urged to move from recumbent to sitting position.
Table 4: Side effects
Side effect 2 h postoperatively 4 h postoperatively
Control (n = 38) Gabapentin (n = 38) Control (n = 38) Gabapentin (n = 38)
Nausea
None/Mild 36 38 34 35
M o d e r a t e / S e v e r e 2043
Sedation
None/Mild 15 19 25 17
Moderate/Severe 23 19 13 21
Dizziness
None/Mild 29 28 28 26
Moderate/Severe 9 10 10 12
Vomiting
1 time or more 33
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